Rainbow Robotics, targeting the’medical robot market’, listed on the KOSDAQ today

Jeongho Lee, CEO of Rainbow Robotics.

Jeongho Lee, CEO of Rainbow Robotics.

Robot platform company Rainbow Robotics will be listed on the KOSDAQ today.

Rainbow Robotics, which is listed on the KOSDAQ market on the 3rd, conducted a general public offering subscription on the 27th, and as a result, the competition rate recorded 1201.26:1.

The subscription margin came in 3,183.3 billion won. The offering price is 10,000 won.

An official of Rainbow Robotics said, “After listing, we will be reborn as a robot platform specialist in a true sense that can create new markets in various fields and change the world with robot technology.”

Established in 2011, Rainbow Robotics is a robot specialized company that developed HUBO, the first humanoid bipedal robot in Korea. We are developing and supplying products such as bipedal walking robots, quadruped walking robots, collaborative robots, and astronomical mount systems. As of last year’s 3rd and 4th quarter, the company recorded sales of 3.8 billion won and an operating loss of 800 million won, but a special case for technology growth companies (recommended for growth) He is on the KOSDAQ.

Rainbow Robotics has been recognized for its technology by supplying bipedal robots to a number of domestic and international research institutes, universities, and companies, such as Massachusetts Institute of Technology (MIT), Google, and the US Naval Research Center.

In particular, Rainbow Robotics is targeting the global medical aesthetic robot market by converging robot application technologies in the medical industry. The company plans to focus its efforts on entering the medical robot market, such as developing a’robot laser toning system’ that automates laser procedures.

The laser toning system is selected by the Ministry of Food and Drug Safety as a new technology medical device license assistant program and can be released after being certified by the Ministry of Food and Drug Safety. It will be mainly supplied to dermatology, plastic surgery, and obstetrics and gynecology that perform laser treatment. Lee Jung-ho, CEO of Rainbow Robotics, said, “We will secure treatment data and develop innovative treatment methods based on this” at the IPO (public disclosure) conference held last month.

CEO Lee said, “A lot of development must be done in the future until the robot is applied to our real life.” “Rainbow Robotics will be at the center of it.” He added, “Through this listing, we will establish itself as a truly global robotics company that can change the world with robot technology.”

Copyright holder ⓒ Money S of’Economic News of People Who Dream of Success’, unauthorized reproduction and redistribution prohibited

.Source